FDA Approves Brexucabtagene Autoleucel for B-Cell Precursor Acute Lymphoblastic Leukemia
October 4th 2021A single infusion of the CAR T-cell therapy Tecartus produced a high and durable response rate in heavily pretreated patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
Read More
Study: Medications, Surgery May Help Obesity-Related High Blood Pressure in Lieu of Diet, Exercise
October 1st 2021The national guidelines recommend a heart-healthy diet to help manage weight and control blood pressure, while also emphasizing dietary patterns rather than individual foods and nutrients.
Read More
The Impact of the FDA's Project Optimus on Oncology Drug Trials
October 1st 2021In an interview with Pharmacy Times®, Maria Whitman, Global Head of the Pharmaceutical and Biotech Practice at ZS, discusses the FDA’s Project Optimus, the FDA’s new guidance addressing dose optimization issues in oncology clinical trials, and how it has impacted drug manufacturers.
Watch